Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

HCWB

$2.43-3.19%

HCW Biologics Inc.

Market Cap
$5M
Sector
Materials
Industry
Biotechnology
Beta
2.27
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
27.1x
buying
Congress
—
recent trades
Short Volume
5%
W/W -31.1pp

Market & Alt Data

News
8
recent articles
Activist
13D
Wong
Analyst Consensus
Strong Buy
7 analysts
Velocity Score
27.08x
Current Rate (90d)
3744.40/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
5
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-07-292026-07-31Flowers LeeSVP of Business DevelopmentPurchase7,736$2.58$20K8,691View
2026-07-292026-07-31Wong Hing CDirector & Chief Executive OfficerPurchase23.2K$2.58$60K125.8KView
2026-05-222026-05-27Wong Hing CDirector & Chief Executive OfficerPurchase113.9K$1.41$160K615.8KView
2026-05-222026-05-27GARRETT SCOTT TDirectorPurchase177.9K$1.41$250K203.4KView
2026-05-222026-05-27Byam RebeccaChief Financial OfficerPurchase14.2K$1.41$20K57.2KView

Recent News

HCW Biologics Signs Akron Biotech Distribution Deal for CAR-T Manufacturing Reagent
Yahoo Finance · 2026-09-08
HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells
Yahoo Finance · 2026-09-08
HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment
Yahoo Finance · 2026-09-02
HCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells

Informational purposes only, not investment advice.

Yahoo Finance · 2026-08-25
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter
Yahoo Finance · 2026-06-30
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026
Yahoo Finance · 2026-06-26
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
Yahoo Finance · 2026-06-16
E.F. Hutton & Co. Serves as Sole Placement Agent on HCW Biologics Inc. $4.0 Million Private Placement
Yahoo Finance · 2026-05-22

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →